Summary
Results from the identification of safety issues, hazard assessment and exposure measurements will be drawn together subsequently to identify common and bespoke findings from across individual partners’ sites and activities, to inform the development of industry-focussed guidance in WP 7 on the safe production and handling of the nanoparticles, nano-containing intermediates and products developed and any necessary control measures to minimise the risk to human health amongst workers, researchers and end-users.
More information & hyperlinks